Role of CD20 expression and other pre-treatment risk factors in the development of infusion-related reactions in patients with CLL treated with obinutuzumab
- Resource Type
- Article
- Source
- Leukemia; August 2016, Vol. 30 Issue: 8 p1763-1766, 4p
- Subject
- Language
- ISSN
- 08876924; 14765551